Ludolph A - Search Results

1

Preface: promoting research in PLS: current knowledge and future challenges.

Mitsumoto H, Turner MR; all Delegates of the PLS Conference; Ajroud-Driss S, Andres P, Andrews J, Gomez EA, Atehortua JMS, Babu S, Barohn R, Bede P, Benatar M, Chew S, Conwit R, Corcia P, Cudkowicz M, Davis F, Carvalho M, Drory V, Elman L, Factor-Litvak P, Fernandes JAM, Ferrey D, Finegan E, Fink J, Floeter MK, Fournier C, Genge A, Govindarajan R, Granit V, Haase G, Hardiman O, Harms M, Hayat G, Heiman-Patterson T, Hill B, Hübers A, Huey E, Jawdat O, Kano O, Kau K, Kiernan M, Kisanuki Y, Kurent J, Kwan J, Lange D, Ludolph A, Mackenzie I, Manfredi G, Marren D, Morita M, Murphy J, Nations S, Oskarsson B, Paganoni S, Pellerin D, Ravits J, Rezania K, Rouleau G, Scelsa S, Siddique T, Siddique N, Silani V, Simmons Z, Statland J, Traynor B, Blitterswijk MV, Berg LVD, Walk D, Warden D, Wymer J. Mitsumoto H, et al. Among authors: ludolph a. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(sup1):1-2. doi: 10.1080/21678421.2020.1840795. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 33602018 Free article. No abstract available.

2

Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.

Leigh PN, Swash M, Iwasaki Y, Ludolph A, Meininger V, Miller RG, Mitsumoto H, Shaw P, Tashiro K, Van Den Berg L. Leigh PN, et al. Among authors: ludolph a. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Jun;5(2):84-98. doi: 10.1080/14660820410020187. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15204010 Review.

3

Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.

Ludolph AC, Bendotti C, Blaugrund E, Hengerer B, Löffler JP, Martin J, Meininger V, Meyer T, Moussaoui S, Robberecht W, Scott S, Silani V, Van Den Berg LH; ENMC Group for the Establishment of Guidelines for the Conduct of Preclinical and Proof of Concept Studies in ALS/MND Models. Ludolph AC, et al. Amyotroph Lateral Scler. 2007 Aug;8(4):217-23. doi: 10.1080/17482960701292837. Amyotroph Lateral Scler. 2007. PMID: 17653919

4

Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Brettschneider J, Kurent J, Ludolph A, Mitchell JD. Brettschneider J, et al. Among authors: ludolph a. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005226. doi: 10.1002/14651858.CD005226.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2013 Jun 05;(6):CD005226. doi: 10.1002/14651858.CD005226.pub3 PMID: 18646122 Updated. Review.

5

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.

Meininger V, Drory VE, Leigh PN, Ludolph A, Robberecht W, Silani V. Meininger V, et al. Among authors: ludolph a. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):378-83. doi: 10.3109/17482960902803432. Amyotroph Lateral Scler. 2009. PMID: 19922128 Clinical Trial.

6

Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?

Felbecker A, Camu W, Valdmanis PN, Sperfeld AD, Waibel S, Steinbach P, Rouleau GA, Ludolph AC, Andersen PM. Felbecker A, et al. Among authors: ludolph ac. J Neurol Neurosurg Psychiatry. 2010 May;81(5):572-7. doi: 10.1136/jnnp.2009.192310. J Neurol Neurosurg Psychiatry. 2010. PMID: 20460594 Free article.

7

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, Lehnert S, Malaspina A, Parnetti L, Petzold A, Shaw P, Sherman A, Steinacker P, Süssmuth S, Teunissen C, Tumani H, Wuolikainen A, Ludolph A; Volcano Group. Otto M, et al. Among authors: ludolph a. Amyotroph Lateral Scler. 2012 Jan;13(1):1-10. doi: 10.3109/17482968.2011.627589. Amyotroph Lateral Scler. 2012. PMID: 22214350 Free article. Review.

8

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH. Turner MR, et al. Among authors: ludolph a. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1(0 1):19-32. doi: 10.3109/21678421.2013.778554. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23678877 Free PMC article. Review.

9

Peer recommendations on how to improve clinical research, and Conference wrap-up.

Chad DA, Rowland LP, Armon C, Bedlack R, Durham H, Factor-Litvak P, Heiman-Patterson T, Heitzman D, Lacomis D, Ludolph A, Maragakis N, Miller R, Pattee G, Shoesmith C, Sorenson E, Turner MR. Chad DA, et al. Among authors: ludolph a. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:67-73. doi: 10.3109/21678421.2013.778605. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23678882

10

Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Brettschneider J, Kurent J, Ludolph A. Brettschneider J, et al. Among authors: ludolph a. Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD005226. doi: 10.1002/14651858.CD005226.pub3. Cochrane Database Syst Rev. 2013. PMID: 23740607 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,056 results

Search Page

Filters